INCRUSE ELLIPTA 62.5MCG BLS 30DS

Sold Per Pack

Incruse Ellipta (62.5 mcg) is a prescription inhaler used for managing chronic obstructive pulmonary disease (COPD). The active ingredient, umeclidinium, is a long-acting anticholinergic that helps to keep the airways open by blocking acetylcholine, a neurotransmitter responsible for airway constriction. This action helps reduce symptoms such as shortness of breath and wheezing, making it easier for individuals to breathe throughout the day.

Administered once daily, Incruse Ellipta provides consistent, long-term control of COPD symptoms. It is designed for ongoing use and is not intended for immediate relief of acute symptoms. The inhaler contains enough medication for a 30-day supply, ensuring a steady dose over the month to help maintain respiratory function and improve quality of life for COPD patients.